CMTx Biotech
Phase 1Developing medical countermeasures against high priority CBRN threats.
Founded
2019
Focus
Small Molecules
About
Developing medical countermeasures against high priority CBRN threats.
Company Info
TypePrivate
Founded2019
LocationCambridge, United States
StagePhase 1
Contact
Sectors
SIMILAR COMPANIES
BASi Research Products
Pre-clinical · West Lafayette
Bay BioSciences
Pre-clinical · San Francisco
EydisBio
Pre-clinical · Cambridge
3Spine
Pre-clinical · Memphis
Belcher Pharmaceuticals
Pre-clinical · Miami
Is this your company?
Claim your profile to update information, add pipeline data, and connect with investors.
Claim profile